BR112012031667A2 - composição - Google Patents

composição

Info

Publication number
BR112012031667A2
BR112012031667A2 BR112012031667A BR112012031667A BR112012031667A2 BR 112012031667 A2 BR112012031667 A2 BR 112012031667A2 BR 112012031667 A BR112012031667 A BR 112012031667A BR 112012031667 A BR112012031667 A BR 112012031667A BR 112012031667 A2 BR112012031667 A2 BR 112012031667A2
Authority
BR
Brazil
Prior art keywords
composition
avaible
abstract
Prior art date
Application number
BR112012031667A
Other languages
English (en)
Inventor
Daniel E Dobry
David K Lyon
David T Vodak
Dwayne T Friesen
Warren K Miller
William B Caldwell
Original Assignee
Dow Global Technologies Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Priority to US35452510P priority Critical
Application filed by Dow Global Technologies Llc filed Critical Dow Global Technologies Llc
Priority to PCT/US2011/040222 priority patent/WO2011159626A1/en
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44627135&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112012031667(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Publication of BR112012031667A2 publication Critical patent/BR112012031667A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B13/00Preparation of cellulose ether-esters
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/08Cellulose derivatives
    • C08L1/32Cellulose ether-esters
BR112012031667A 2010-06-14 2011-06-13 composição BR112012031667A2 (pt)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US35452510P true 2010-06-14 2010-06-14
PCT/US2011/040222 WO2011159626A1 (en) 2010-06-14 2011-06-13 Hydroxypropyl methyl cellulose acetate succinate with enhanced acetate and succinate substitution

Publications (1)

Publication Number Publication Date
BR112012031667A2 true BR112012031667A2 (pt) 2016-11-08

Family

ID=44627135

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012031667A BR112012031667A2 (pt) 2010-06-14 2011-06-13 composição

Country Status (11)

Country Link
US (1) US9040033B2 (pt)
EP (1) EP2579896B1 (pt)
JP (1) JP5792807B2 (pt)
KR (1) KR101807338B1 (pt)
CN (1) CN103153343B (pt)
BR (1) BR112012031667A2 (pt)
CA (1) CA2801712A1 (pt)
CO (1) CO6660473A2 (pt)
IL (1) IL223607A (pt)
MX (1) MX2012014849A (pt)
WO (1) WO2011159626A1 (pt)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
KR101944124B1 (ko) * 2010-11-24 2019-01-30 멜린타 서브시디어리 코프. 약학 조성물
US20150004237A1 (en) * 2012-01-09 2015-01-01 Virginia Tech Intellectual Properties, Inc. Cellulose derivatives for inhibiting crystallization of poorly water-soluble drugs
CN104245741B (zh) * 2012-03-27 2017-05-24 陶氏环球技术有限责任公司 一种制备纤维素醚的酯的方法
EP2836205B1 (en) 2012-04-11 2016-10-19 Dow Global Technologies LLC Esterified cellulose ethers having a specific substituent distribution
CN102807625A (zh) * 2012-08-23 2012-12-05 浙江中维药业有限公司 一种醋酸羟丙甲纤维素琥珀酸酯的制备方法
CN104755503B (zh) * 2012-08-24 2018-03-06 陶氏环球技术有限责任公司 在脂族羧酸的存在下制备纤维素醚的酯的方法
US20150218291A1 (en) * 2012-08-24 2015-08-06 Dow Global Technologies Llc Process of preparing an esterified cellulose ether in the presence of an alkali metal carboxylate and an aliphatic carboxylic acid
KR20150044958A (ko) * 2012-08-24 2015-04-27 다우 글로벌 테크놀로지스 엘엘씨 알칼리 금속 카복실레이트의 존재하의 셀룰로스 에테르의 에스테르의 제조 방법
BR112015002058A2 (pt) 2012-08-24 2017-07-04 Dow Global Technologies Llc éter de celulose esterificado parcialmente reticulado, composição, dispersão sólida, processo para produzir a dispersão sólida, forma de dosagem e invólucro de cápsula
KR20150045510A (ko) * 2012-08-24 2015-04-28 다우 글로벌 테크놀로지스 엘엘씨 신규한 하이드록시알킬 메틸 셀룰로즈 아세테이트 석시네이트
BR112015021179A2 (pt) * 2013-03-01 2017-07-18 Hercules Inc composições farmacêuticas com melhor desempenho e melhor processabilidade
KR101661952B1 (ko) * 2013-03-07 2016-10-04 다우 글로벌 테크놀로지스 엘엘씨 극저점도의 신규한 에스테르화된 셀룰로스 에테르
JP6321688B2 (ja) * 2013-03-07 2018-05-09 ダウ グローバル テクノロジーズ エルエルシー 低粘度の新規エステル化セルロースエーテル
JP6334574B2 (ja) * 2013-03-07 2018-05-30 ダウ グローバル テクノロジーズ エルエルシー 新規の超高分子量のエステル化セルロースエーテル
JP6321689B2 (ja) * 2013-03-07 2018-05-09 ダウ グローバル テクノロジーズ エルエルシー 新規の低粘度及び高分子量のエステル化セルロースエーテル
EP2997046B1 (en) 2013-05-14 2019-09-25 Dow Global Technologies LLC Cellulose ethers esterified with dicarboxylic acids
EP2810660B1 (en) 2013-06-03 2017-07-26 Shin-Etsu Chemical Co., Ltd. Composition for hot-melt extrusion and method for producing hot-melt extrusion product using same
KR101674912B1 (ko) * 2013-09-23 2016-11-10 다우 글로벌 테크놀로지스 엘엘씨 반응 생성물 혼합물로부터 에스테르화된 셀룰로스 에테르를 회수하기 위한 방법
KR20150079412A (ko) * 2013-12-31 2015-07-08 삼성정밀화학 주식회사 입도분포가 조절된 히드록시프로필 메틸셀룰로오스 아세테이트 숙시네이트(hpmcas) 입자의 제조방법 및 hpmcas 분말
US20160347866A1 (en) * 2014-02-20 2016-12-01 Dow Global Technologies Llc Novel esterified cellulose ethers of high molecular weight and homogeneity
EP3186285A1 (en) 2014-08-27 2017-07-05 Dow Global Technologies LLC Esterified cellulose ethers of low acetone-insoluble content
CA2964068A1 (en) * 2014-09-19 2016-03-24 Board Of Regents, The University Of Texas System Methods of preparing extrudates
CN104311674A (zh) * 2014-10-17 2015-01-28 广东东阳光药业有限公司 一种混合酯的制备方法
BR112017008431A2 (pt) * 2014-10-31 2018-01-23 Dow Global Technologies Llc processo para produzir um acetato succinato éter de celulose
JP6273076B2 (ja) 2014-10-31 2018-01-31 ダウ グローバル テクノロジーズ エルエルシー セルロースエーテルのエステルを調製するための効率的な方法
CN107074980A (zh) * 2014-10-31 2017-08-18 陶氏环球技术有限责任公司 制备纤维素醚的酯的方法
JP6203702B2 (ja) 2014-11-18 2017-09-27 信越化学工業株式会社 ヒプロメロース酢酸エステルコハク酸エステルを用いたスプレードライ用溶液及び固体分散体の製造方法
JP6295380B2 (ja) * 2015-03-16 2018-03-14 ダウ グローバル テクノロジーズ エルエルシー 脂肪族カルボン酸の存在下でエステル化セルロースエーテルを調製するためのプロセス
US20180072820A1 (en) 2015-03-16 2018-03-15 Dow Global Technologies Llc Gelling esterified cellulose ethers
CN107636019B (zh) * 2015-03-16 2019-02-26 陶氏环球技术有限责任公司 水溶性酯化纤维素醚
KR20170128358A (ko) 2015-03-16 2017-11-22 다우 글로벌 테크놀로지스 엘엘씨 낮은 중화도를 갖는 수용성 에스테르화 셀룰로오스 에테르
MX2017011096A (es) 2015-03-16 2017-11-10 Dow Global Technologies Llc Solucion acuosa de un eter de celulosa esterificado.
BR112017023845A2 (pt) 2015-05-15 2018-07-31 Dow Global Technologies Llc processo de preparação de um éter de celulose esterificado de peso molecular elevado
BR112017023272A2 (pt) 2015-05-15 2018-08-07 Dow Global Technologies Llc processo para produzir éteres de celulose esterificados de peso molecular muito elevado e baixa viscosidade
BR112018001792A2 (pt) * 2015-07-28 2018-09-11 Dow Global Technologies Llc processo para produzir dispersão de éter de celulose esterificado
CN108348466A (zh) * 2015-12-08 2018-07-31 陶氏环球技术有限责任公司 包含纤维素醚和水溶性酯化纤维素醚的组合物
US9884922B2 (en) * 2016-03-11 2018-02-06 Shin-Etsu Chemical Co., Ltd. Hypromellose acetate succinate, method for producing the same and composition containing the same
EP3529281A1 (en) * 2016-10-18 2019-08-28 Dow Global Technologies LLC Efficient process of preparing an esterified cellulose ether
US20180116968A1 (en) * 2016-11-02 2018-05-03 Shin-Etsu Chemical Co., Ltd. Hypromellose acetate succinate and method for producing the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4226981A (en) 1977-09-28 1980-10-07 Shin-Etsu Chemical Co., Ltd. Ether-ester derivatives of cellulose and their applications
JP2528706B2 (ja) 1988-05-30 1996-08-28 ゼリア新薬工業株式会社 ジヒドロピリジン化合物の製剤組成物
EP1741424B1 (en) * 1997-08-11 2018-10-03 Pfizer Products Inc. Solid pharmaceutical dispersions with enhanced bioavailabilty
PT901786E (pt) 1997-08-11 2007-08-07 Pfizer Prod Inc Disperções farmacêuticas sólidas com biodisponibilidade melhorada
WO2002038126A2 (en) 2000-11-08 2002-05-16 Aeromatic-Fielder Ag A process for production of particles for pharmaceutical compositions having increased bioavailability
CA2568007A1 (en) 2004-05-28 2005-12-08 Pfizer Products Inc. Pharmaceutical compositions with enhanced performance
CN101299993A (zh) * 2005-11-04 2008-11-05 伊士曼化工公司 用于给药难溶的药学活性剂的羧烷基纤维素酯

Also Published As

Publication number Publication date
JP5792807B2 (ja) 2015-10-14
CN103153343A (zh) 2013-06-12
MX2012014849A (es) 2013-05-01
CN103153343B (zh) 2015-02-11
US20130102691A1 (en) 2013-04-25
KR20130109102A (ko) 2013-10-07
EP2579896B1 (en) 2016-07-20
CO6660473A2 (es) 2013-04-30
JP2013532151A (ja) 2013-08-15
WO2011159626A1 (en) 2011-12-22
KR101807338B1 (ko) 2018-01-10
CA2801712A1 (en) 2011-12-22
EP2579896A1 (en) 2013-04-17
IL223607A (en) 2016-04-21
US9040033B2 (en) 2015-05-26

Similar Documents

Publication Publication Date Title
BR112013010185A2 (pt) composições pesticidas e processos relacionados às mesmas
BR112013021985A2 (pt) proteção de agulha
BR112013021997A2 (pt) migração externa ao vivo
BR112012000624A2 (pt) método
BRPI1011587A2 (pt) compostos e composições terapèuticas
BRPI1014984A2 (pt) turbocompressor
BR112013002845A2 (pt) combinação de susbtâncias ativas
BR112012006964A2 (pt) ventilador
BR112012022323A2 (pt) dispositivo de iluminação
BRPI1006519A2 (pt) formulação de anticorpos
BRPI0924604A2 (pt) refrigerador
BRPI1013335A2 (pt) composição compósita
BR112012024284A2 (pt) composição de fusão de polímero
BR112013012082A2 (pt) 5-halogenopirazolcarboxamidas
BRPI1016125A2 (pt) meio de ancoragem
BRPI1009599A2 (pt)
BR112012017441A2 (pt) compostos e métodos
BR112013012584A2 (pt) polímero acrílico
BR112013014614A2 (pt) misturas de glicosídeo
BR112013002286A2 (pt) disposição de vedação para rolamentos
BR112013014361A2 (pt) forma de dosagem
BRPI1009562A2 (pt)
BRPI1006125A2 (pt) óculos
BR112013014986A2 (pt) compostos inseticidas
BR112013008856A2 (pt) compostos de sulfonamida e métodos pra fazer e usar os mesmos

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law
B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B07E Notice of approval relating to section 229 industrial property law

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06T Formal requirements before examination
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete